© PHIRE | All rights reserved
Where PHIRE comes from
The EDIT Project
The PHIRE project focuses on results generated by the European project EDIT (GA no. 801126. October 1, 2018 – September 30, 2022) a multidisciplinary FET-Open (EIC Pathfinder called today) project funded under H2020. The project, composed by 9 international partners, has demonstrated the feasibility of an innovative strategy for the detection of bladder cancer lesions smaller than 1 mm combining newly developed targeted imaging technologies (high-resolution ultrasound elastography and photoacoustic imaging) on the bladder using plasmonic gold sensors for enhanced resolution.
Start date/End date
01-10-2018 30-09-2022
EU Contribution
Coordinated By
OSPEDALE SAN RAFFAELE SRL
Play Video
EDIT was selected from the European Commission to receive further supports in the form of trainings, for the participation to:
- the FET2RIN meeting, a 3-way workshop to support FET projects (i.e., EDIT) to reach out investors and make a larger impact on society (5th edition – 2018/2019 Winter Edition)
- the 15th edition of the EIC Innovation Training Workshop (11-12 May 2022)
- the Horizon Results Booster grant (50.000 Euro) to undertake complementary activities to explore potential pathways for Portfolio Dissemination & Exploitation Strategy, Business Plan Development of EDIT KERs.
EDIT outcomes were selected as innovative by the European Commission’s Innovation Radar team for the following topics:
- Targeted nanoparticles for early diagnosis and treatment of bladder Cancer
- 3D Reconstruction and visualization of the bladder and the bladder tumour combining US and PA images, further granted through a H2020-FETOPEN LAUNCHPAD (AIR3D, GA# 101034880).
Moreover, the EDIT outcomes were also highlighted through a press release in CORDIS: “Pioneering technology delivers early cancer diagnosis and treatment” (10 February 2023).
